Emergent BioSolutions Inc.
As of Oct 16, 2026 close
- Market cap
- $370.49M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.36$14.06
- Volume (live)
- -
- Avg. volume (3M)
- 1.15M
Emergent BioSolutions (EBS) Stock Price & Financial Analysis
Emergent BioSolutions Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $6.15 - $6.73 |
|---|---|
| 52-Week High | $14.06 |
| 52-Week Low | $4.36 |
| Open | $6.64 |
| Volume (last close) | 2.24M |
| Average Volume (3M) | 1.15M |
| Revenue (TTM) | 747.20M |
|---|---|
| Net Income (TTM) | -176.80M |
| Free Cash Flow (TTM) | 85.90M |
| EPS (TTM) | −$3.26 |
| Profit Margin | -23.66% |
| Operating Margin | 18.28% |
| Return on Equity (ROE) | -51.79% |
| Debt to Equity | 1.70 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Last Dividend Ex-Date | Aug 1, 2016 |
| Market Cap | 370.49M |
|---|---|
| Shares Outstanding | 51.60M |
| Price to Sales (P/S) | 0.50 |
| Price to Book (P/B) | 1.09 |
| EV/EBITDA | -1160.84 |
| 50-Day MA | $6.07 |
|---|---|
| 200-Day MA | $8.38 |
| 1-Year Change | −21.62% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Emergent BioSolutions at a Glance
As of the Oct 16, 2026 close, Emergent BioSolutions (EBS) has a market capitalization of $370.49M. The stock trades at 0.5× sales. Over the trailing twelve months it lost $176.80M on revenue of $747.20M and generated $85.90M of free cash flow. Revenue fell 9.8% year over year.
As of its latest reported balance sheet, it holds $139.70M in cash and securities against $581.80M of debt, a net debt position of $442.10M.
Emergent BioSolutions does not currently pay a dividend.
The share price is down 21.6% over the past year. At $6.38 (the Oct 16, 2026 close) it sits within its 52-week range of $4.36 to $14.06, below its 200-day moving average of $8.38.
Based on 2 professional analyst ratings from the past 90 days, the consensus is Hold.
Frequently Asked Questions About Emergent BioSolutions
What is the current stock price for EBS?
As of the Oct 16, 2026 close, EBS stock trades at $6.38. The 52-week range is $4.36–$14.06, with a day range of $6.15–$6.73.
What is the P/E ratio for EBS?
The P/E ratio (Price-to-Earnings) for EBS is shown in the Key Statistics section. This valuation metric helps compare Emergent BioSolutions Inc. to industry peers.
Does EBS pay dividends?
Emergent BioSolutions does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for EBS?
Based on ratings from 2 professional analysts over the last 90 days, the consensus for EBS is Hold.
What is the market cap of EBS?
As of the Oct 16, 2026 close, Emergent BioSolutions's market capitalization is $329.2M, classifying it as a small-cap company. Emergent BioSolutions operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.